Home › Funds › Castleview Partners, LLC › DOCT

Castleview Partners, LLC position in DOCT

FIRST TR EXCHNG TRADED FD VI

Castleview Partners, LLC reported holding 32,358 shares of DOCT (FIRST TR EXCHNG TRADED FD VI) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.68% of its reported portfolio and ranking #30 among its reported holdings. Castleview Partners, LLC has disclosed DOCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)32.36K sh
Reported value held$1.55M
Portfolio Weight0.68%
First reportedQ4 2024
Last changeHold
Updated2026-10-10

Last updated: 2026-10-10 · Source: SEC EDGAR Form 13F-HR

How Castleview Partners, LLC's DOCT position evolved

Castleview Partners, LLC first disclosed a stake in DOCT in Q4 2024 at 39,668 shares (US$1.6M). Across 8 filings, Castleview Partners, LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 32,358 shares valued at US$1.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 39.67K $1.56M New
Q1 2025 35.14K $1.35M Reduce
Q2 2025 29.93K $1.23M Reduce
Q3 2025 29.82K $1.29M Hold
Q4 2025 33.04K $1.46M Add
Q1 2026 32.85K $1.43M Reduce
Q2 2026 32.29K $1.51M Reduce
Q3 2026 32.36K $1.55M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DOCT and 13F data

DOCT (FIRST TR EXCHNG TRADED FD VI) is a company whose sector is not yet classified in our data. 36 other funds we track also report a position in DOCT — the largest reported positions include OGOREK ANTHONY JOSEPH /NY/ /ADV (US$13.3M), REAP Financial Group, LLC (US$10.0M), Wood Tarver Financial Group, LLC (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DOCT

All DOCT fund holders →

FAQ

How long has Castleview Partners, LLC held DOCT?

Castleview Partners, LLC has disclosed DOCT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Castleview Partners, LLC's current position in DOCT?

As of Q3 2026, Castleview Partners, LLC holds 32.36K shares of DOCT (FIRST TR EXCHNG TRADED FD VI), valued at $1.55M, representing 0.68% of its reported portfolio and ranking #30.

Has Castleview Partners, LLC been buying or selling DOCT?

In the latest 13F filing (Q3 2026), Castleview Partners, LLC held unchanged its position in DOCT.

Which other funds hold DOCT?

Other major institutional holders of DOCT include OGOREK ANTHONY JOSEPH /NY/ /ADV, REAP Financial Group, LLC, Wood Tarver Financial Group, LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.